Kernal Biologics
Onco-selective mRNA therapeutics company developing in vivo cell therapies through targeted delivery and selective translation for cancer and autoimmune diseases.
About Kernal Biologics
Onco-selective mRNA therapeutics company developing in vivo cell therapies through targeted delivery and selective translation for cancer and autoimmune diseases.
Products
mRNA therapeutics platform that is intelligently programmed and selectively translated, using AI models to ensure selective translation in target cells and enabling scalable in...
T-Cell-Targeted LNPs (lipid nanoparticles) for in situ CAR T programming, enabling targeted delivery to T-cells for in vivo CAR-T therapy generation.
Security and compliance
No security details published yet
Kernal Biologics hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Kernal Biologics